Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Revolution Medicines $273.7 million IPO
Davis Polk advised the underwriters in connection with an initial public offering of 16,100,000 shares of common stock of…
Revance Therapeutics $287.5 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5…
Shockwave Medical $16.5 million supplemental term loan
Davis Polk advised Shockwave Medical, Inc. in connection with a $16.5 million supplemental term loan provided by Silicon…
Theravance Biopharma $148.5 million follow-on offering
Davis Polk advised the underwriters in connection with the $148.5 million public offering of ordinary shares by…
Innovent Biologics HK$2.4 billion placing of shares
Davis Polk advised the sole placing agent for the primary placement of an aggregate of 78,000,000 new shares in Innovent…
Applied Genetic Technologies stock offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 6…
RAPT Therapeutics $75 million follow-on offering
Davis Polk advised the underwriters in connection with a $75 million public offering of common stock by RAPT…
Beam Therapeutics $180 million IPO
Davis Polk advised the joint book-running managers in connection with the $180 million initial public offering of common…
Integra LifeSciences Holdings $575 million convertible senior notes offering
Davis Polk advised the joint book-running managers and representatives of the initial purchasers on a Rule 144A offering by…
1Life Healthcare $282 million IPO
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the …